Skip to content
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands
Subscribe
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
Subscribe
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands
Picture of Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine

At Johnson & Johnson Innovative Medicine, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
Picture of Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine

At Johnson & Johnson Innovative Medicine, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
  • October 12, 2015

Janssen starts clinical trial with ebola vaccin

  • for Johnson & Johnson Innovative Medicine
  • August 24, 2015

A perspective of the future – Towards a cure for cancer and much more

  • for Johnson & Johnson Innovative Medicine
  • August 21, 2015

The Ebola Vaccine: a work in progress

  • for Johnson & Johnson Innovative Medicine
  • July 28, 2015

Ebola diagnostics – faster, safer, and more accurate

  • for Johnson & Johnson Innovative Medicine
  • July 9, 2015

Idylla™ : a lab-in-a-box

  • for Johnson & Johnson Innovative Medicine
  • June 11, 2015

TBC drug Sirturo is the most innovative!

  • for Johnson & Johnson Innovative Medicine
Previous Next

Follow us on

Icon-linkedin Facebook Icon-x Instagram

Stay updated on the latest news!

Subscribe

Want to contact us?

Contact

Interested in our media kit?

Media kit

Stay updated on the latest news!

Subscribe

Want to get in touch?

Contact Us

Follow us on

Icon-linkedin
©2026 BioVox. All rights reserved.
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}